Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.36

-1.18

-0.99

-0.81

Details

Expected EPS

-0.986136

Actual EPS

-0.81

Surprise EPS

0.18

Surprise Percent

+17.86%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.81 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.